HPV Infection and Genital Microecology of Childbearing-age Female in China: A Cohort and Multicenter Study
Launched by ZHUJIANG HOSPITAL · Jan 3, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the relationship between HPV (human papillomavirus) infections, the health of the genital area, and changes in cervical cells in women of childbearing age in China. The aim is to better understand how these factors are connected, which could help in managing HPV-related health issues.
To be eligible for this study, participants need to be women aged between 18 and 62 who have had sexual intercourse and are not currently on their period. They should not have had certain medical treatments or surgeries recently, and they should not have been vaccinated for HPV. If you join the trial, you can expect to undergo a thinprep cytologic test, which is a type of screening to check for abnormalities in cervical cells. This research is still recruiting participants, and your involvement could contribute valuable insights into women's health regarding HPV and cervical conditions.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female of childbearing age conducting thinprep cytologic test
- • Having an experience of sexual intercourse
- • Not during the menstrual period
- • No sexual intercourse or vaginal medication or vaginal flushing in 3 days before sampling
- Exclusion Criteria:
- • Within 8 weeks of pregnancy or postpartum
- • Having had tumors in reproductive tract
- • Having had HPV bivalent, tetravalent or nine-valent vaccination
- • Having received treatment for anti- HPV or other STDs pathogens infection
- • Having had hysterectomy, cervical surgery and pelvic radiotherapy
- • Having used broad-spectrum antibiotics, probiotics or vaginal suppositories in reproductive tract within 1 month
About Zhujiang Hospital
Zhujiang Hospital, affiliated with the Southern Medical University in Guangzhou, China, is a leading clinical research institution dedicated to advancing medical science and improving patient care through rigorous clinical trials. With a strong commitment to ethical standards and patient safety, the hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals. Its state-of-the-art facilities enable the execution of innovative studies across various therapeutic areas, contributing valuable insights to the global medical community. Zhujiang Hospital aims to foster collaboration with academic institutions, pharmaceutical companies, and regulatory bodies to ensure the successful development of new therapies and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jinan, Shandong, China
Xi'an, Shanxi, China
Shenzhen, , China
Guangzhou, Guangdong, China
Yinchuan, Ningxia, China
Shenzhen, Guangdong, China
Yinchuan, Ningxia, China
Changsha, , China
Dongguan, Guangdong, China
Haikou, Hainan, China
Guangzhou, Guangdong, China
Lanzhou, Gansu, China
Kunming, Yunnan, China
Xi'an, , China
Guiyang, Guizhou, China
Luzhou, Sichuan, China
Xi'an, Shanxi, China
Changzhi, Shanxi, China
Guangzhou, , China
Huizhou, Guangdong, China
Shenzhen, Guangdong, China
Shijia Zhuang, Hebei, China
Jilin, Jilin, China
Shenzhen, Guangdong, China
Guangzhou, Tianhe District, China
Hefei, Anhui, China
Chaozhou, Guangdong, China
Foshan, Guangdong, China
Guangzhou, Guangdong, China
Guangzhou, Guangdong, China
Guangzhou, Guangdong, China
Shenzhen, Guangdong, China
Zhongshan, Guangdong, China
Guangzhou, Guangzhou, China
Zhuhai, Guangzhou, China
Zunyi, Guizhou, China
Shaoguan, Gunagdong, China
Qiqihar, Hei Longjiang, China
Lianyungang, Jiangsu, China
Xining, Qinghai, China
Shanghai, Shanghai, China
Lasa, Tibet, China
Hanzhou, Zhejiang, China
Chongqing, , China
Shanghai, , China
Patients applied
Trial Officials
Hongwei Zhou, Doctor
Principal Investigator
Department of Laboratory Medicine, Zhujiang Hospital, Southern Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials